Attached files

file filename
8-K - 8-K - RELIV INTERNATIONAL INCv304173_8k.htm

EXHIBIT 99

NEWS RELEASE

 

For more information, contact:

  

Steve Albright or: Fred Nielson
Chief Financial Officer     Investor Relations
(636) 733-1305      (636) 733-1314

 

FOR IMMEDIATE DISTRIBUTION

 

Reliv International Reports Fourth-Quarter

and Full-Year Financial Results for 2011

 

CHESTERFIELD, Missouri, February 29, 2012 – Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the fourth quarter and full year of 2011.

 

Fourth-Quarter Results

Reliv reported net sales of $16.9 million for the fourth quarter of 2011, compared with sales of $18.5 million for the fourth quarter of 2010. U.S. sales declined by 13.4 percent for the quarter compared with the same quarter in 2010. International sales for the quarter increased 14.4 percent, led by significant growth in Europe, which reported an increase of 83.9 percent.

 

Reliv reported net income of $320,000, or $0.03 per diluted share, for the fourth quarter of 2011 compared with net income of $559,000, or $0.05 per diluted share, for the fourth quarter of 2010. Income from operations for the fourth quarter of 2011 was $471,000 compared with $827,000 in the same quarter of 2010.

 

Full-Year Results

Reliv reported net sales of $73.9 million for 2011 compared with net sales of $78.7 million in 2010. U.S. net sales decreased from $66.9 million to $60.9 million. Net sales in Reliv’s foreign markets for 2011 increased 9.7 percent compared with net sales for 2010. Net sales were particularly strong in Europe, where net sales increased 80.4 percent. Growth in the European market in 2011 was driven by strong increases in new distributor enrollments.

 

Net income for 2011 was $1.0 million compared with $1.7 million in 2010. Diluted earnings per share were $0.08 in 2011 compared with $0.14 in 2010.

 

“The financial highlight of 2011 was the increase in sales in Europe,” said Robert L. Montgomery, chairman, president and chief executive officer of Reliv. “Our European market set numerous monthly sales records in 2011 after posting double digit growth in 2010. This sustained growth is something we plan to build on in 2012.”

 

“In the United States, we have turned to innovation to jump start sales. The introduction of healthy energy shot 24K™ followed with the innovative 24K VIP program, a customer referral and lead generation initiative, I believe positions us to expand our footprint in the lucrative energy drink market,” he said.

 

- MORE -

 
 

 

 

Reliv International Fourth-Quarter Financial Results

ADD ONE

 

 

“In 2011 Reliv became the first corporate partner of the Missouri Plant Science Center. That partnership has produced LunaRich™, our first Reliv-exclusive nutritional ingredient,” Montgomery said. “LunaRich is a unique soy powder, which in comparison to the industry standard, contains five to ten times the amount of soy’s key bioactive component.”

 

“We introduced Reliv Now® as the first product to contain LunaRich this February at the 2012 Reliv National Conference in Reno,” he said. “Backed by clinical studies, LunaRich has energized our distributor base and given us a new competitive edge in the supplement market. We plan to add LunaRich to additional Reliv products in the coming months.”

 

“In Reno we also announced that GlucAffect®, Reliv’s cutting-edge blood sugar management formula, became the sixth Reliv product to earn a patent,” Montgomery said.

 

“As we work to regain sales momentum in the United States, we are focusing on reducing costs and maintaining our strong balance sheet,” he added. Reliv reported a reduction in selling, general and administrative expenses of $532,000 for the fourth quarter of 2011 and $1.25 million for all of 2011 compared with the prior-year periods. Reliv had cash and cash equivalents of $7.2 million as of December 31, 2011, an increase of $843,000 from the balance as of December 31, 2010. Net cash generated from operating activities increased to $2.8 million in 2011 from $2.2 million in 2010.

 

As of December 31, 2011, Reliv had 57,010 distributors – a decline of 6.1 percent from December 31, 2010 – of which 7,670 are Master Affiliate level and above. Master Affiliate is the level at which distributors are eligible to earn generation royalties.

 

About Reliv International, Inc.
Reliv International, Inc., based in Chesterfield, Missouri, produces nutritional supplements that promote optimal nutrition along with premium skincare products. Reliv supplements address essential nutrition, weight loss, athletic performance, digestive health, women's health, anti-aging and healthy energy. The company sells its products through an international network marketing system of independent distributors in 15 countries. Learn more about Reliv at www.reliv.com, or on Facebook, Twitter or YouTube.

Statements made in this news release that are not historical facts are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995) that involve risks and uncertainties and are subject to change at any time. These forward-looking statements may include, but are not limited to, statements containing words such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue” or similar expressions. Factors that could cause actual results to differ are identified in the public filings made by Reliv with the Securities and Exchange Commission. More information on factors that could affect Reliv’s business and financial results are included in its public filings made with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, copies of which are available on the Company’s web site, www.reliv.com.

--FINANCIAL HIGHLIGHTS FOLLOW –

 
 

 

 

 

Reliv International, Inc. and Subsidiaries        
ADD TWO        
         
Condensed Consolidated Balance Sheets        
         
   December 31,   December 31, 
   2011   2010 
   (Unaudited)   (Audited) 
           
Assets          
Current assets:          
Cash and cash equivalents  $7,174,213   $6,331,038 
Accounts receivable,  less allowances of          
$70,300 in 2011 and $67,100 in 2010   334,828    291,405 
Accounts due from employees and distributors   43,191    55,854 
Inventories   4,723,773    5,650,790 
Other current assets   1,136,376    916,239 
Total current assets   13,412,381    13,245,326 
           
Other assets   1,987,213    1,867,976 
Intangible assets, net   1,597,644    1,785,987 
           
Net property, plant and equipment   7,421,947    7,944,412 
           
Total assets  $24,419,185   $24,843,701 
           
           
           
Liabilities and stockholders’ equity          
           
Total current liabilities  $6,110,449   $6,387,164 
Long-term debt, less current maturities   3,566,175    4,150,770 
Other non-current liabilities   256,710    375,244 
           
Total stockholders’ equity   14,485,851    13,930,523 
           
Total liabilities and stockholders’ equity  $24,419,185   $24,843,701 

 

** MORE **

 

 
 

 

Reliv International, Inc. and Subsidiaries                
ADD THREE                
                 
Consolidated Statements of Operations                
                 
   Three months ended December 31,   Year ended December 31, 
   2011   2010   2011   2010 
   (Unaudited)   (Unaudited)   (Unaudited)   (Audited) 
                 
Product sales  $15,007,686   $16,474,506   $65,701,343   $70,033,580 
Handling & freight income   1,877,845    2,052,935    8,178,557    8,714,808 
                     
Net sales   16,885,531    18,527,441    73,879,900    78,748,388 
                     
Costs and expenses:                    
Cost of products sold   3,468,769    3,645,518    15,105,416    15,738,885 
Distributor royalties and commissions   6,312,062    6,889,546    27,629,167    29,450,171 
Selling, general and administrative   6,634,021    7,165,656    29,400,219    30,652,045 
                     
Total costs and expenses   16,414,852    17,700,720    72,134,802    75,841,101 
                     
Income from operations   470,679    826,721    1,745,098    2,907,287 
                     
Other income (expense):                    
Interest income   7,662    12,410    40,508    47,744 
Interest expense   (33,618)   (46,649)   (138,967)   (205,985)
Other income   10,635    54,518    24,518    76,110 
                     
Income before income taxes   455,358    847,000    1,671,157    2,825,156 
Provision for income taxes   135,000    288,000    623,000    1,142,000 
                     
Net income  $320,358   $559,000   $1,048,157   $1,683,156 
                     
Earnings per common share - Basic  $0.03   $0.05   $0.08   $0.14 
Weighted average shares   12,409,000    12,389,000    12,429,000    12,382,000 
                     
Earnings per common share - Diluted  $0.03   $0.05   $0.08   $0.14 
Weighted average shares   12,410,000    12,389,000    12,429,000    12,383,000 
                     
Cash dividends declared per common share  $0.01   $0.02   $0.04   $0.04 

 

** MORE ** 

 

 
 

 

 

Reliv International, Inc. and Subsidiaries                
ADD FOUR                        
                         
Net sales by Market                        
(in thousands)                        
   Three months ended December 31,       Change From 
   2011   2010   Prior Year 
   Amount   % of sales   Amount   % of sales   Amount   % 
                         
United States  13,444    79.6%   15,518    83.8%   (2,074)   -13.4%
Australia/New Zealand   597    3.5%   624    3.4%   (27)   -4.3%
Canada   470    2.8%   525    2.8%   (55)   -10.5%
Mexico   219    1.3%   328    1.8%   (109)   -33.2%
Europe   1,175    7.0%   639    3.4%   536    83.9%
Asia   981    5.8%   893    4.8%   88    9.9%
                               
Consolidated total   16,886    100.0%   18,527    100.0%   (1,641)   -8.9%

 

Net sales by Market                              
(in thousands)                              

   Year ended December 31,       Change From 
   2011   2010   Prior Year 
   Amount   % of sales   Amount   % of sales   Amount   % 
                         
United States  60,884    82.4%   66,896    85.0%   (6,012)   -9.0%
Australia/New Zealand   2,374    3.2%   2,548    3.2%   (174)   -6.8%
Canada   2,139    2.9%   2,159    2.8%   (20)   -0.9%
Mexico   1,201    1.6%   1,435    1.8%   (234)   -16.3%
Europe   3,753    5.1%   2,080    2.6%   1,673    80.4%
Asia   3,529    4.8%   3,630    4.6%   (101)   -2.8%
                               
Consolidated total   73,880    100.0%   78,748    100.0%   (4,868)   -6.2%

 

The following table sets forth, as of December 31, 2011 and 2010, the number of our active distributors and Master Affiliates and above
The total number of active distributors includes Master Affiliates and above.  We define an active distributor as one that enrolls as a
distributor or renews its distributorship during the prior twelve months.  Master Affiliates and above are distributors that have attained
the highest level of discount and are eligible for royalties generated by Master Affiliates and above in their downline organization
Growth in the number of active distributors and Master Affiliates and above is a key factor in continuing the growth of our business
 

 

Active Distributors and Master Affiliates and above by Market                
                   Change From 
   As of 12/31/2011   As of 12/31/2010   Prior Year 
     Active Distributors    Master Affiliates and Above     Active Distributors    Master Affiliates and Above     Active Distributors    Master Affiliates and Above 
                               
United States  $43,280    6,080    47,450    6,990    -8.8%   -13.0%
Australia/New Zealand   1,950    170    2,210    190    -11.8%   -10.5%
Canada   1,300    220    1,380    200    -5.8%   10.0%
Mexico   1,260    220    1,850    300    -31.9%   -26.7%
Europe   3,850    430    2,170    300    77.4%   43.3%
Asia   5,370    550    5,680    620    -5.5%   -11.3%
                               
Consolidated total   57,010    7,670    60,740    8,600    -6.1%   -10.8%

 

 

**30 **